AllDocs -> cancers

SEER Cancer Statistics Review 1975-2000 National Cancer Institute Cancer Facts & Figures – 2003, American Cancer Society (ACS), Atlanta, Georgia, 2003. Excludes basal and squamous cell skin and in situ carcinomas except urinary bladder. Incidence projections are based on rates from the NCI SEER Program 1979-1999. a Estimated deaths for colon & rectum cancers are combined. b Carcinoma in situ of the breast accounts for about 55,700 new cases annually, and melanoma in situ accounts for about 37,700 new cases annually. c More deaths than cases suggests lack of specificity in recording underlying causes of death on death certificate. Estimated New Cases Estimated Deaths Primary Site Total Males Females Total Males Females All Sites 1,334,100 675,300 658,800 556,500 285,900 270,600 ...

48S JADA, Vol. 132, November 2001 W hile the rates of oral cancer have dropped in the last 20 years, health agencies still anticipate that it will be diagnosed in more than 30,000 Ameri- cans this year. Of those 30,000, two- thirds are men. Knowing the risk factors as well as the signs of oral cancer can go a long way toward limiting the influence this disease can have on your life. KNOW WHAT TO LOOK FOR As with many forms of cancer , early detection of oral cancerous lesions can improve the chances of suc- cessful treatment. You can take an active role in detecting signs of oral cancer early by checking your oral tissues periodically. Take a few minutes to examine your lips, gums, cheek lining and tongue, as well as the floor and roof of your mouth. You’ll want to note any of the following: d a color ...

03/07/29: BC Cancer Foundation & Fraser Valley motorcyclists greet Dare to Dream team: BC Cancer Agency Agency Links: Hom e Contact Us Legal Privacy Search Site Map Patient/Public Info | Regional Services | Health Professionals Info | About BCCA | Research | Donating Foundation Home >> Newsroom >> News Releases >> 2003 >> 03/07/29: BC Cancer Foundation & Fraser Valley motorcyclists greet Dare to Dream team News Releases 2003 03/07/16: Biker rides into Fraser Valley in support of ovarian cancer 03/05/03: Motorcycle Legacy Opens Road For Future Cancer Research 03/04/28: BC Cancer Foundation to honour Trev and Joyce Deeley for cancer research support 03/07/29: BC Cancer Foundation & Fraser Valley motorcyclists ...

Research Scholar Grant Policies July 2003 AMERICAN CANCER SOCIETY RESEARCH SCHOLAR GRANTS POLICIES Research Scholar Grants in Basic, Preclinical, Clinical and Epidemiology Research Research Scholar Grants in Psychosocial, Behavioral and Cancer Control Research Research Scholar Grants in Health Services and Health Policy Research January 2003 This revision supercedes all previous Research Scholar Grant Policies AMERICAN CANCER SOCIETY, INC. Extramural Grants Department 1599 Clifton Road, NE Atlanta, Georgia 30329-4251 Voice: (404) 329-7558 Fax: (404) 321-4669 Web site: http://www. cancer .org Email: grants@ cancer .org MISSION The American Cancer Society is the nationwide, community-based, voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer , saving lives and diminishing ...

relieved even with limited resources, 3 vastly improving a patient’s quality of life. Effective pain relief requires consistent, ongoing, and timely provision of tailored dosages of analgesic medications. Along with home remedies and analgesic medications, palliative care for advanced cervical cancer also can involve therapies such as palliative radiotherapy (single or short course) and chemotherapy. These therapies can help shrink the advancing growth, relieving discomfort, pain, and malodorous vaginal discharge, and decreasing the tendency for the tumor to hemorrhage. Pain management is a priority in palliative care Pain associated with advanced cancer can often be alleviated, but it is a problem that is frequently neglected. Globally, several million people with cancer suffer unnecessarily from pain every ...

Integrated Integrated Bioinformatics for Bioinformatics for Cancer Studies and Cancer Studies and the GRID the GRID Dr. James Brenton Dr. Sam Aparicio Prof. Carlos Caldas Page 2 Genomics Challenge Genomics Challenge • • Find ways to describe Find ways to describe germline/somatic cancer germline/somatic cancer alterations in a way that alterations in a way that unravels patterns that are unravels patterns that are consistent and predictive of consistent and predictive of outcomes outcomes • • Learn how to use this Learn how to use this knowledge for improved knowledge for improved cancer management ...

Use of Chemotherapy in Advanced Unresectable or Metastatic Transitional Cell Carcinoma of the Bladder or Urothelium Practice Guideline Report #3-12 Members of the Genitourinary Disease Site Group Report Date: June 19, 2002 SUMMARY Guideline Question What is the optimal chemotherapeutic regimen for patients with advanced unresectable or metastatic cancer of the bladder or urothelium? Overall and progression-free survival, toxicity, quality of life, and clinical improvement are the outcomes of interest. Target Population These recommendations apply to adult patients with advanced unresectable or metastatic transitional cell carcinoma of the bladder or urothelium. Recommendations * • Chemotherapy with gemcitabine-cisplatin (GC) or dose-intense methotrexate, vinblastine, doxorubicin, and cisplatin given with granulocyte-colony stimulating factor ...

Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer Practice Guideline Report # 3-1 Report Date: February 5, 2003 Members of the Genitourinary Disease Site Group SUMMARY Guideline Question Does maximal androgen blockade (MAB) (orchiectomy or luteinizing hormone-releasing hormone [LHRH] agonist plus administration of an antiandrogen) provide superior overall survival or progression-free survival compared with castration alone (orchiectomy or LHRH agonist) in previously untreated men with metastatic prostate cancer ? The outcomes of interest are survival, disease-free or progression-free survival, adverse effects, and quality of life. Target Population These recommendations apply to adult men with metastatic prostate cancer (D1 or D2 1 , N+/M0 or M1). Recommendations • MAB should not be routinely ...

Cancer Care Ontario Practice Guidelines Initiative Sponsored by: Cancer Care Ontario Ontario Ministry of Health and Long-Term Care Use of 5-HT 3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy Practice Guideline Report #12-3 ORIGINAL GUIDELINE: March 7, 2000 MOST RECENT LITERATURE SEARCH: January 2003 NEW EVIDENCE ADDED TO GUIDELINE REPORT: January 2003 New evidence found by update searches since completion of the original guideline is consistent with the recommendations below. SUMMARY Guideline Questions 1. Are the 5-HT3 receptor antagonists ondansetron, granisetron and dolasetron equivalent in terms of efficacy and adverse effects? 2. Should 5-HT3 receptor antagonists be administered for more than 24 hours following chemotherapy to prevent delayed-onset emesis? Target Population ...

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer Practice Guideline Report No. 7-4 ORIGINAL GUIDELINE: September 15, 1997 UPDATE: April 2002 This summary integrates the original practice guideline with the most current information (labeled NEW). SUMMARY Guideline Question Should preoperative (neoadjuvant) cisplatin-based chemotherapy, with or without postoperative radiotherapy, be offered to patients with technically resectable stage IIIA non- small cell lung cancer (NSCLC), in order to improve survival? Resectability should be determined preoperatively by a thoracic surgeon. Target Population These recommendations apply to adult patients with technically resectable Stage IIIA NSCLC, as determined by a thoracic surgeon. Recommendations • Stage ...

Workplace Health and Safety Queensland Rural Safety Link 4. Skin Cancer • Malignant Melanoma - the most dangerous type of skin cancer . Often starts as a dark mole. This type is responsible for over 1200 deaths in Australia each year. • Sunspot (Solar Keratosis) - a small scaly patch of skin occurring on the arms, face, nose and ears. They are not strictly a form of cancer but indicate excessive exposure to solar UV radiation. 2. Protection All persons on the farm including children should be encouraged to protect themselves against the sun. • Highest risk time in the sun is between 10.00am and 3.00pm. • Wear protective clothing, ie a shady hat, collared shirt in a dark, close weave fabric with long sleeves and trousers. Queensland’s skin cancer rate is already the highest ...

Use of Strontium 89 in Patients with Endocrine-Refractory Carcinoma of the Prostate Metastatic to Bone Practice Guideline Report # 3-6 Brundage MD, Crook JM, Lukka H and the G enitourinary Cancer Disease Site Group ORIGINAL GUIDELINE: November 23, 1997 UPDATE: October 2001 This summary integrates the original practice guideline with the most current information (labeled NEW). Part 1: Strontium 89 treatment for hormone refractory prostate cancer skeletal metastases: multiple painful sites of disease Guideline Question What is the role of Strontium 89 in effective palliation of patients with stage D endocrine- refractory prostate cancer and multiple sites of painful bony metastases? Target Population These recommendations apply to adult patients with stage D endocrine-refractory prostate cancer ...

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced-Stage, Aggressive Histology Non- Hodgkin’s Lymphoma Practice Guideline Report #6-7 Report Date: June 25, 2003 SUMMARY Guideline Questions 1. What treatment provides the optimum disease control and survival in older patients (at least 60 years of age) with newly diagnosed, advanced-stage, aggressive histology lymphoma? 2. What are the toxicities associated with these treatments? 3. What are the roles of granulocyte-colony stimulating factor or granulocyte macrophage- colony stimulating factor in combination with chemotherapy in these patients? Target Population These recommendations apply to patients older than age 60 who have newly diagnosed, advanced-stage, aggressive histology non-Hodgkin’s lymphoma, an Eastern Cooperative Oncology Group (ECOG) performance status of less than ...

World Summit Against Cancer , Paris, 9 February 2001, UNESCO Opening address by Donald J. Johnston General-Secretary of the OECD Introduction First, I wish to thank most sincerely Professors Kayat and Hortobagyi for inviting me to say a few words at the opening of this important Conference. There were several reasons why I wish to come here today, some personal and some professional. With respect to the latter, health is an issue of major concern, not only for Members of the OECD community, but for the global community. At the last Ministerial meeting of OECD Ministers in June 2000, we were mandated to intensify our work in health, and I will describe some of that work which is relevant to the issues before us in a few moments. My personal reasons are those probably shared by many of you in this room. Many loved ones, family and friends, have been taken from me prematurely by this terrible disease. I lost my ...

Researchers on Front Lines Against Cancer One of two Americans living today will get cancer . But talk to Kenneth Cowan, M.D., Ph.D., director of the University of Nebraska Medical Center’s Eppley Cancer Center, and you’ll soon feel optimistic instead of pessimistic. The war on cancer began in 1970, and since that time huge strides have been made. “We see the fruits of the research,” Cowan says. “It’s led to a decrease in the incidence of cancer and an increase in survival of patients who develop cancer . We believe this is just the beginning.” If there is anything he’s more positive about, it’s the role UNMC’s Eppley Cancer Center will play. Cowan cited several examples of promising work at the center, particularly in the area of cancer vaccines. Julie Vose, M.D., is ...

Colorectal cancer screening pilot Colorectal cancer facts June 2003 Page 1 of 2 COLORECTAL CANCER SCREENING PILOT PROJECT COLORECTAL CANCER FAST FACTS Almost all cases of colorectal cancer begin with the development of benign or non-cancerous polyps. Polyps develop when cells lining the colon reproduce too quickly. These polyps can become cancerous, invading the colon wall and surrounding blood vessels and spreading to other parts of the body. Incidence and Mortality Ontario has one of the highest rates of colorectal cancer in the world. Colorectal cancer is the second leading cancer killer for both men and women. • In 2002, it was estimated that 6,600 Ontario residents would be diagnosed with colorectal cancer and about 2,300 would die of the disease. • The probability of curing colorectal cancer is 90 percent when it is detected ...

United States Cancer Statistics 1999 INCIDENCE PUBLICATION YEAR 2002 DEPARTMENT OF HEALTH AND HUMAN SERVICES Page 2 Suggested citation: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999 Incidence . Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2002. All material in this report is in the public domain and may be reproduced or copied without permission. However, citation as to source is requested. National Program of Cancer Registries (NPCR) National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention 4770 Buford Highway, MS K-53 Atlanta, GA 30341-3717 Phone: (770) 488-4783 Fax: (770) 488-4759 Web address: http://www.cdc.gov/ cancer /npcr/ ...

What Is Colorectal Cancer ? Colorectal cancer is cancer that occurs in the colon or rectum. Sometimes it is called colon cancer , for short. As the drawing shows,the colon is the large intestine or large bowel. The rectum is the passageway that connects the colon to the anus. The 2nd-Leading Cancer Killer Colorectal cancer is the 2nd-leading cancer killer in the United States,but it doesn’t have to be. If everybody age 50 or older had regular screening tests,at least one-third of deaths from this cancer could be avoided. So,if you are 50 or older,start getting tested now. Who Gets Colorectal Cancer ? • Men and women of any racial or ethnic group can get colorectal cancer . • Colorectal cancer most often is found in people 50 and older. • As we get older,the risk for getting colorectal ...

The Role of the Taxanes in the Management of Metastatic Breast Cancer Practice Guideline Report # 1-3 S Verma, M Trudeau, K Pritchard, T Oliver, and members of the Breast Cancer Disease Site Group Report Date: April 24, 2003 SUMMARY Guideline Question What is the role of the taxanes in the management of metastatic breast cancer ? Target Population These recommendations apply to women with metastatic breast cancer for whom first- or greater-line chemotherapy is being considered outside the context of a clinical trial. Recommendations In anthracycline-naive patients, who would ordinarily be offered treatment with a single-agent anthracycline (doxorubicin or epirubicin) or an anthracycline in a standard combination, the following options are also reasonable: • Treatment with single-agent docetaxel 100 mg/m 2 over one hour ...

RECOMMENDATIONS ON CANCER SCREENING IN THE EUROPEAN UNION PREPARED BY THE ADVISORY COMMITTEE ON CANCER PREVENTION AFTER THE CONFERENCE ON SCREENING AND EARLY DETECTION OF CANCER Vienna 18 th – 19 th November 1999 1. INTRODUCTION 2. GENERAL PRINCIPLES 3. CERVICAL CANCER SCREENING 3.1 Epidemiology 3.2 Present situation 3.3 Recommendations 3.3.1 To the Member States 3.3.2 To the European Commission and the European Parliament 4. BREAST CANCER SCREENING 4.1 Epidemiology 4.2 Present situation 4.3 Recommendations 4.3.1 To the Members States 4.3.2 To the European Commission and European Parliament 5. COLORECTAL CANCER SCREENING 5.1 Epidemiology 5.2 Present situation 5.3 Recommendations 5.3.1 To Member States 5.3.2 To European Commission and Parliament 6. PROSTATE ...

Asian Pacific Journal of Cancer Prevention, Vol 3, 2002 281 National Cancer Center, Korea CANCER RESEARCH INSTITUTE National Cancer Center, Korea Mission and Objectives The National Cancer Center (NCC) has a mission to reduce the incidence and mortality of cancer by means of specialized research, quality care, education & training, and national cancer control programs, and consequently to promote national health and welfare. In order to achieve its mission the NCC has the following functions: - Basic and clinical cancer research ; - Clinical oncology services for cancer patients; - Education and training for medical professionals and experts from industry, academia, institutes and government; - Implementing of the national cancer control programs: cancer statistics & registration, prevention, early detection ...

Organizing Committee Raymond N. DuBois, Chairperson, Vanderbilt University, Nashville, TN Ernest T. Hawk, National Cancer Institute, Bethesda, MD William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA Paul Kleihues, International Agency for Research on Cancer , Lyon, France Scott M. Lippman, UT M.D. Anderson Cancer Center, Houston, TX Barbara K. Rimer, University of North Carolina, Chapel Hill, NC Margaret R. Spitz, UT M.D. Anderson Cancer Center, Houston, TX Makoto Mark Taketo, Kyoto University, Kyoto, Japan Scientific Committee Lucile L. Adams-Campbell, Howard University Cancer Center, Washington, DC Jasjit Ahluwalia, University of Kansas, Kansas City, KS Demetrius Albanes, National Cancer Institute, Bethesda, MD David S. Alberts, University of Arizona Cancer Center, Tucson, AZ Carolyn R. Aldigé, ...

How Common Is Colorectal Cancer ? Colorectal cancer — cancer of the colon or rectum—is the second leading cause of cancer -related death in the United States.The American Cancer Society estimates that 57,100 Americans will die of colorectal cancer this year. Colorectal cancer is also one of the most commonly diagnosed cancers in the United States;approximately 147,500 new cases will be diagnosed in 2003. Colorectal cancer is the third most common cancer in men and in women. Who Is at Risk? The risk for developing colorectal cancer increases with advancing age. Risk factors include inflammatory bowel disease, a personal or family history of colorectal cancer or colorectal polyps, and certain hereditary syndromes. Lack of regular physical activity also contributes to a person’s risk for colon cancer ...

Dr. Terry Sullivan Vice President, Research and Prevention Cancer Care Ontario Targeting Cancer an action plan for cancer prevention and detection Page 2 What is Cancer 2020? • Ambitious targets aimed to reduce the incidence of cancer • A solid provincial plan to expand cancer prevention and early detection • Medium term targets and short-term priorities • A framework to monitor progress Page 3 How Did We Come Up with Cancer 2020? • Initiated at the request of the Ministry of Health and Long-Term Care • Led by a Steering Committee of leaders drawn from the cancer control community • Creative use of scenarios, careful review of surveys, research and established forecasting methods • Result is an ambitious but achievable ...

1 of 3 June 2002 CANCER FACT SHEET 1 General Cancer Statistics • An estimated 136,900 new cases of cancer and 66,200 deaths from cancer will occur in Canada in 2002. • Despite significant progress against cancer , it remains the second leading cause of death in Canada. Cancer is the leading cause of premature death in Canada, and is responsible for almost one-third of all potential years of life lost. • In recent years (1994–98), cancer was diagnosed, on average, in 1,262 Canadian children, of whom an average of 239 died each year. The most common childhood cancer is leukemia, which accounts for over 26 per cent of new cases and 32 per cent of deaths. • Cancers of the brain and spinal cord, the second most common group of childhood cancers after leukemia, constituted approximately 17 per cent of new cases and 25 ...

1 of 2 June 2002 Cancer in Ontario Cancer is the most important health problem facing Ontario. More than 50,000 Ontarians are diagnosed with cancer each year. It is estimated that this number will increase by 40% over the next 10 years. And, as better treatments become available the demand for services can be expected to increase at a rate 7–10% per year. Cancer isn't just a common disease but it's also a complex disease to manage. Patients require many different services delivered by many different health care professionals. Diagnosis and treatment are complicated and expensive. Before Cancer Care Ontario was created in 1997, there was no system to coordinate cancer services across the province. Who We Are Cancer Care Ontario is a provincial government agency completely dedicated to cancer control. Our job is to make sure that all Ontario residents have equal access to the same ...

Living with Cancer Cancer Society Contacts Cancer Society of New Zealand Inc. National Office PO Box 10847, Wellington Tel: (04) 494 7270 Auckland Division PO Box 1724, Auckland Tel: (09) 308 0160 Covering: Northland Waikato/Bay of Plenty Division PO Box 134, Hamilton Tel: (07) 838 2027 Covering: Tauranga, Rotorua Central Districts Division PO Box 5096, Palmerston North Tel: (06) 364 8989 Covering: Taranaki, Wanganui, Manawatu, Hawkes Bay and Gisborne Wellington Division 52 Riddiford Street, Wellington Tel: (04) 389 8421 Covering: Marlborough, Nelson, Wairarapa and Wellington Canterbury/West Coast Division PO Box 13450, Christchurch Tel: (03) 379 5835 Covering: South Canterbury, West Coast, Ashburton Otago/Southland Division PO Box 6258, Dunedin Tel: (03) ...